Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Abraxane
Abraxane
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Mon, 05/5/14 - 05:02 pm
Merrimack Pharmaceuticals
pancreatic cancer
MM-398
Gemzar
Eli Lilly
Celgene
Abraxane
Celgene's Abraxane Under Fire in NEJM Letter
TheStreet.com
Thu, 01/30/14 - 10:10 am
New England Journal of Medicine
Abraxane
Celgene
pancreatic cancer
breast cancer
lung cancer
Abraxane's Approval for Pancreatic Cancer Is a Major Milestone for Celgene
Motley Fool
Mon, 09/30/13 - 11:40 am
Celgene
pancreatic cancer
Abraxane
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Mon, 09/16/13 - 11:48 am
Celgene
FDA
Bristol-Myers Squibb
AbbVie
JNJ
Eli Lilly
Revlimid
Abraxane
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Sat, 09/14/13 - 11:00 am
Celgene Corporation
Abraxane
pancreatic cancer
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Fri, 09/13/13 - 08:27 am
Celgene
pancreatic cancer
Abraxane
F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
NY Times
Sat, 09/7/13 - 11:45 am
Abraxane
Celgene
pancreatic cancer
OncoGenex's Apatorsen in Phase II Study
Yahoo/Zacks
Thu, 08/29/13 - 09:40 am
OncoGenex
apatorsen
metastatic pancreatic cancer
Gemzar
Celgene
Abraxane
OGX-427
Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Motley Fool
Mon, 06/10/13 - 10:56 am
Celgene
Abraxane
pancreatic cancer
Novartis
Pfizer
Celgene at ASCO: Ho-Hum, Ho-Hum, and Hmmm
Motley Fool
Wed, 06/5/13 - 12:24 pm
Celgene
ASCO
Pomalyst
Abraxane
Revlimid
3 FDA Stories You Missed This Week
Motley Fool
Sat, 06/1/13 - 12:46 pm
Merck
suvorexant
insomnia
sleep aid
hypnotics
Celgene
Abraxane
prostate cancer
Glaxo
Tafinlar
dabrafenib
melanoma
New Pancreatic Cancer Drug an FDA Priority
Motley Fool
Sun, 05/26/13 - 11:20 am
pancreatic cancer
Celgene
Abraxane
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thu, 04/4/13 - 09:13 am
Celgene
Eli Lilly
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Pomalyst
Revlimid
Abraxane
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
lung cancer
Roche
Avastin
Tarceva
Astellas
Pfizer
Xalkori
Celgene
Abraxane
Gemzar
Alimta
Eli Lilly
Celgene’s Abraxane Benefits Pancreatic Cancer Patients
Bloomberg
Wed, 01/23/13 - 10:40 am
Celgene
Abraxane
pancreatic cancer
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Thu, 11/29/12 - 11:05 am
Revlimid
Celgene
Vidaza
Abraxane
apremilast
pomalidomide
Abraxane Cancer Trials Help Justify Celgene Buyout
investors.com
Sat, 11/17/12 - 02:03 pm
Abraxane
Celgene
pancreatic cancer
2 Reasons You Should Love This Biotech's Good News
Motley Fool
Tue, 11/13/12 - 11:12 am
Celgene
pancreatic cancer
Abraxane
Celgene Rises as Abraxane Meets Pancreatic Cancer Goals
Bloomberg
Mon, 11/12/12 - 10:57 am
Celgene
pancreatic cancer
Abraxane
Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
Seeking Alpha
Sun, 11/11/12 - 09:56 am
pancreatic cancer
Celgene
Abraxane
Pages
« first
‹ previous
1
2
3
next ›
last »